Asian Scientist Magazine

Bristol-Myers Squibb: 52-Week High Recently Eclipsed (BMY)
Financial News Network Online
The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Bristol-Myers Squibb share prices have moved between a 52-week ...
Bristol-Myers Squibb Booked a New
Bristol-Myers Squibb: Major Shareholders Supporting Shares in Q3Wall St. Cheat Sheet

all 85 news articles »